相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Introducing the Endotype Concept to Address the Challenge of Disease Heterogeneity in Type 1 Diabetes
Manuela Battaglia et al.
DIABETES CARE (2020)
Autoantigen Treatment in Type 1 Diabetes: Unsolved Questions on How to Select Autoantigen and Administration Route
Johnny Ludvigsson
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Precision Medicine in Diabetes: A Consensus Report From the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Wendy K. Chung et al.
DIABETES CARE (2020)
Efficacy of GAD-alum immunotherapy associated with HLA-DR3-DQ2 in recently diagnosed type 1 diabetes
Ulf Hannelius et al.
DIABETOLOGIA (2020)
Glutamic Acid Decarboxylase Injection Into Lymph Nodes: Beta Cell Function and Immune Responses in Recent Onset Type 1 Diabetes Patients
Rosaura Casas et al.
FRONTIERS IN IMMUNOLOGY (2020)
Golimumab and Beta-Cell Function in Youth with New-Onset Type 1 Diabetes
T. Quattrin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
HbA1c level as a risk factor for retinopathy and nephropathy in children and adults with type 1 diabetes: Swedish population based cohort study
Marcus Lind et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
Intralymphatic Immunotherapy: Update and Unmet Needs
Gabriela Senti et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2019)
Low-Dose Anti-Thymocyte Globulin (ATG) Preserves -Cell Function and Improves HbA1c in New-Onset Type 1 Diabetes
Michael J. Haller et al.
DIABETES CARE (2018)
Methyldopa blocks MHC class II binding to disease-specific antigens in autoimmune diabetes
David A. Ostrov et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: a nationwide, register-based cohort study
Araz Rawshani et al.
LANCET (2018)
GAD vaccine reduces insulin loss in recently diagnosed type 1 diabetes: findings from a Bayesian meta-analysis
Craig A. Beam et al.
DIABETOLOGIA (2017)
More on Intralymphatic Injection of Autoantigen in Type 1 Diabetes
Michael Haller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Intralymphatic Injection of Autoantigen in Type 1 Diabetes
Johnny Ludvigsson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Metabolic and immune effects of immunotherapy with proinsulin peptide in human new-onset type 1 diabetes
Mohammad Alhadj Ali et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Genetic and Environmental Interactions Modify the Risk of Diabetes-Related Autoimmunity by 6 Years of Age: The TEDDY Study
Jeffrey P. Krischer et al.
DIABETES CARE (2017)
The clinical potential of low-level C-peptide secretion
Johnny Ludvigsson
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2016)
Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients
Mark R. Rigby et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Cellular and Humoral Immune Responses in Type 1 Diabetic Patients Participating in a Phase III GAD-alum Intervention Trial
Stina Axelsson et al.
DIABETES CARE (2013)
GAD65 Antigen Therapy in Recently Diagnosed Type 1 Diabetes Mellitus
Johnny Ludvigsson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial
Diane K. Wherrett et al.
LANCET (2011)
Teplizumab for treatment of type 1 diabetes (Protege study): 1-year results from a randomised, placebo-controlled trial
Nicole Sherry et al.
LANCET (2011)
Sample Size Requirements for Studies of Treatment Effects on Beta-Cell Function in Newly Diagnosed Type 1 Diabetes
John M. Lachin et al.
PLOS ONE (2011)
No Protective Effect of Calcitriol on β-Cell Function in Recent-Onset Type 1 Diabetes The IMDIAB XIII trial
Carla Bizzarri et al.
DIABETES CARE (2010)
New Definition for the Partial Remission Period in Children and Adolescents with Type 1 Diabetes
Henrik B. Mortensen et al.
DIABETES CARE (2009)
Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function
Mark D. Pescovitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Mixed-Meal Tolerance Test Versus Glucagon Stimulation Test for the Assessment of β-Cell Function in Therapeutic Trials in Type 1 Diabetes
Carla J. Greenbaum et al.
DIABETES CARE (2008)
Nasal insulin to prevent type 1 diabetes in children with HLA genotypes and autoantibodies conferring increased risk of disease: a double-blind, randomised controlled trial
Kirsti Nanto-Salonen et al.
LANCET (2008)
GAD treatment and insulin secretion in recent-onset type 1 diabetes
Johnny Ludvigsson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Intralymphatic allergen administration renders specific immunotherapy faster and safer: A randomized controlled trial
Gabriela Senti et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Direct intralymphatic injection of peptide vaccines enhances immunogenicity
P Johansen et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2005)
Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus
KC Herold et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Intralymphatic immunization enhances DNA vaccination
KJ Maloy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Vitamin D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells
L Piemonti et al.
JOURNAL OF IMMUNOLOGY (2000)
分享论文
